PharmaEngine Cash Flow Reinvestment Rate
PharmaEngine cash flow reinvestment rate. PharmaEngine (4162) has a Cash Flow Reinvestment Rate of 8.59x as of September 2025, reinvesting NT$455.53 Million (capex NT$115.00K plus investments NT$-455.41 Million) from operating cash flow of NT$53.01 Million. Explore PharmaEngine (4162) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of PharmaEngine (2011–2024)
Cash flow reinvestment rate of PharmaEngine from 2011 to 2024. Historical reinvestment intensity for PharmaEngine across 12 annual periods. Explore PharmaEngine capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
PharmaEngine Cash Flow Reinvestment Rate by Year (2011–2024)
PharmaEngine cash flow reinvestment rate by year from 2011 to 2024. Year-by-year capital reinvestment analysis for PharmaEngine. For the full cash flow conversion analysis, see how efficiently does PharmaEngine generate cash.
| Year | Reinvestment Rate | Total Reinvested (TWD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.25x | NT$116.09 Million | NT$456.73 Million | NT$1.42 Million | ▼ -92.4% |
| 2023 | 3.33x | NT$856.44 Million | NT$256.97 Million | NT$958.00K | ▲ +258.3% |
| 2022 | 0.93x | NT$187.92 Million | NT$202.01 Million | NT$3.94 Million | ▲ +721.8% |
| 2021 | 0.11x | NT$105.23 Million | NT$929.67 Million | NT$229.00K | ▼ -99.6% |
| 2020 | 27.26x | NT$1.77 Billion | NT$64.77 Million | NT$608.00K | ▲ +2267.7% |
| 2019 | 1.15x | NT$18.51 Million | NT$16.08 Million | NT$208.00K | ▲ +42.4% |
| 2018 | 0.81x | NT$602.36 Million | NT$745.23 Million | NT$510.00K | ▲ +8.1% |
| 2016 | 0.75x | NT$650.89 Million | NT$870.38 Million | NT$1.15 Million | ▼ -87.7% |
| 2015 | 6.10x | NT$2.73 Billion | NT$447.99 Million | NT$11.80 Million | ▲ +841249.6% |
| 2014 | 0.00x | NT$95.00K | NT$131.09 Million | NT$95.00K | ▼ -40.1% |
| 2012 | 0.00x | NT$83.00K | NT$68.64 Million | NT$83.00K | ▼ -58.7% |
| 2011 | 0.00x | NT$806.00K | NT$275.49 Million | NT$806.00K | — |